supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago
Research Papers that Mention the Interaction
“We estimated that 16.8 g of patiromer will increase fecal potassium by 1880 μg/g and reduce serum potassium by 0.5 mEq/L. Thus, there is a complex interaction between stool and blood potassium, calcium and magnesium during patiromer treatment.”
The potassium regulator patiromer affects serum and stool electrolytes in patients receiving hemodialysis.“ Patiromer and SZC were found to reduce potassium with less side effects.”
“ConclusionsPre-treatment with patiromer decreases the potassium concentration of infant formula.”
“ResultsFollowing pre-treatment with patiromer , the potassium concentration of both formulas decreased.”
“Additional research is also warranted in the potential safety benefits of reducing potassium fluctuations in patients on hemodialysis as a result of treatment of hyperkalemia with patiromer.”
“New data suggest that treatment with patiromer or sodium zirconium cyclosilicate for up to 8 weeks reduces plasma potassium levels in hyperkalaemic patients.”
“ Patiromer , a drug that binds to potassium and decreases its absorption from the gastrointestinal tract, has been approved for the treatment of hyperkalemia, FDA and Relypsa Inc. announced on October 21.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback